Bolivia Medical Device Regulation: SNUS Procurement, CEASS Supply and Price Compliance

1. Key takeaways

Public procurement in Bolivia is organised through the Single National Supply System (Sistema Nacional Único de Suministro, SNUS), established by Decreto Supremo N° 26873 and governed by Resolución Ministerial N° 0735. The Health Supply Centre (CEASS) is the executing body responsible for the supply and distribution of medicines and medical devices. Section 1.2 of the Manual para Registro Sanitario de Dispositivos Médicos anchors the manual itself to DS N° 26873, which shows that the device registration regime and the public supply system were designed within one institutional framework. GRZAN’s conclusion is that public procurement in Bolivia is not a sales channel that follows registration; it is a condition to be built into the registration plan from the outset.

That conclusion changes the sequence of a market entry project. In many markets a manufacturer registers first and thinks about tenders later, treating public demand as an additional revenue opportunity. In Bolivia the public system is the principal route through which devices reach health facilities, so the requirements of that system, from packaging configuration to delivery geography, feed back into product specification and therefore into the registration file.

A registration that is technically valid but commercially unsuited to the supply system costs the same as one that is not, and delivers less.

2. Legal basis

The four instruments describe one chain of authority. DS N° 26873 creates the supply system and defines its scope; R.M. N° 0735 sets the rules under which that system operates; section 1.2 of the manual links the registration regime to the decree, so that the health registration is positioned as an input to the supply system rather than as a parallel track; and Circular MSyD/AGEMED/CR/1/2021 carries the price notification that determines whether a registered product is eligible to be purchased. The registration is therefore necessary but not sufficient, and the additional conditions are published outside the device manual.

3. Expert insights

Insight 1: the manual cites the SNUS decree in its purpose clause, which shows that registration and supply are connected. The reference in section 1.2 to DS N° 26873 is not a formal courtesy. It indicates that the registration regime was designed with the selection, programming, procurement, storage, distribution and rational use cycle of the public supply system in view. A company designing product specifications should therefore consider how the product will perform inside that cycle, including pack sizes suited to facility-level dispensing and shelf life that survives central storage before onward distribution.

Insight 2: price compliance is directly linked to procurement eligibility. AGEMED publishes the price list through Circular MSyD/AGEMED/CR/1/2021 (6 January 2021), on the basis of Article 1(e) and Article 59 of Ley N° 1737. The price and speculation provisions are hard constraints written into the medicines law, and they apply to devices as well; the point is developed in article 47 of this series. A product that cannot be offered within the notified framework is not merely less competitive, it may be ineligible.

Insight 3: tender specifications go down to delivery and penalties. Bolivian public tender documents typically state the delivery batches, the delivery locations, including CEASS warehouses and health facilities across the country, the allocation of transport and packaging responsibility, and liquidated damages calculated per day of delay. These requirements fall outside AGEMED’s remit yet determine whether a contract can be performed. A company should assess delivery capability as a separate item before bidding, rather than treating it as a consequence of winning.

Insight 4: the supply system rewards planning that begins before the tender. Selection and programming decisions inside SNUS determine what is bought and in what quantities, and they are taken before a tender is published. A manufacturer that engages only at the tender stage competes on price for volumes that were already configured around another specification. Engaging earlier, through the importer’s commercial relationships, is a legitimate part of market access and should be planned alongside the registration.

4. Practical recommendations

1. Move public procurement requirements forward to the product specification stage, including pack configuration, storage conditions and distribution radius.
2. Assess price compliance obligations early, and build the price notification regime into the market launch plan rather than treating it as a post-registration matter.
3. Evaluate delivery capability independently before bidding, with particular attention to the cost of multi-batch delivery across the national network.
4. Model the penalty exposure in the tender terms, including liquidated damages per day of delay, and confirm that the importer can absorb it before a bid is submitted.

5. Verification checklist

• □ The target product falls within the scope of public procurement
• □ Selection and programming information under the SNUS system is available
• □ Price compliance obligations have been assessed
• □ Product specifications suit the storage and distribution conditions of the public system
• □ Delivery and penalty clauses in the tender documents have been assessed against performance capability

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers, importers and authorised representatives with registration in Bolivia, including alignment of the registration plan with the SNUS framework under Decreto Supremo N° 26873 and Resolución Ministerial N° 0735, assessment of price notification obligations, and review of specification and delivery requirements before a public tender is entered. For assistance with a public procurement or market access plan for Bolivia, contact the GRZAN regulatory team at info@grzanglobal.com.

GRZAN applies a writing standard of conclusions first, traceable sources and verifiable figures to its regulatory publications, and follows the practice of AGEMED, CEASS and the other authorities cited in this series as it develops. For a market access plan that treats public procurement as part of the registration design rather than an afterthought, the team welcomes your enquiry.